Fulgent Genetics (FLGT) Operating Expenses (2015 - 2026)

Fulgent Genetics (FLGT) has 12 years of Operating Expenses data on file, last reported at $56.1 million in Q1 2026.

• Quarterly Operating Expenses rose 16.56% year-over-year to $56.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $229.9 million (up 24.04% YoY) and the FY2025 annual result came in at $222.0 million, up 22.55% from the prior year.
• Operating Expenses fell to $56.1 million in Q1 2026 per FLGT's latest filing, from $68.8 million in the prior quarter.
• The five-year high for Operating Expenses was $176.4 million in Q4 2023, with the low at $39.6 million in Q3 2023.
• Average Operating Expenses over 5 years is $55.7 million, with a median of $48.0 million recorded in 2024.
• Year-over-year, Operating Expenses soared 255.98% in 2023 and sank 72.79% in 2024.
• Fulgent Genetics' Operating Expenses stood at $49.5 million in 2022, then soared by 255.98% to $176.4 million in 2023, then sank by 72.79% to $48.0 million in 2024, then surged by 43.42% to $68.8 million in 2025, then dropped by 18.47% to $56.1 million in 2026.
• Business Quant data shows FLGT's Operating Expenses at $56.1 million in Q1 2026, $68.8 million in Q4 2025, and $50.9 million in Q3 2025.